EDGAR Filing Documents for 0001047469-18-005260

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001047469-18-005260

Filing Date

2018-07-27

Accepted

2018-07-27 16:45:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2236323zs-3.htm	S-3	413620
2	EX-4.2	a2236323zex-4_2.htm	EX-4.2	541602
3	EX-4.4	a2236323zex-4_4.htm	EX-4.4	162005
4	EX-4.5	a2236323zex-4_5.htm	EX-4.5	167711
5	EX-4.6	a2236323zex-4_6.htm	EX-4.6	147283
6	EX-5.1	a2236323zex-5_1.htm	EX-5.1	33325
7	EX-23.1	a2236323zex-23_1.htm	EX-23.1	3167
8	G559309.JPG	g559309.jpg	GRAPHIC	18224
9	G684570.JPG	g684570.jpg	GRAPHIC	3772
10	G177842LAI001.GIF	g177842lai001.gif	GRAPHIC	1964
	Complete submission text file	0001047469-18-005260.txt		1503127

Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713

Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487

Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)